UNSPSC 51273946: Menthol/petrolatum/pramoxine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE700. This VA Drug Class (DE700) classifies this compound as belonging to the group LOCAL ANESTHETICS, TOPICAL.

UNSPSC 51273946 Menthol/petrolatum/pramoxine is a Commodity code that does not align with the state and local procurement activity currently tagged to it. The recent opportunities posted under this code reflect pharmaceutical procurement at scale — naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products — none of which match the topical analgesic product scope the code nominally describes. The mismatch suggests either a classification error in the source data or that the code has been repurposed beyond its original intent. State and local buying offices, health departments, pharmacy benefit programs, and multistate cooperative purchasing organizations are the issuing bodies, but their actual solicitation activity does not track to the menthol/petrolatum/pramoxine commodity line.

Recent opportunities include Seminole County, Florida's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023); the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs (April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026, with July 1, 2026 contract effective date). The code shows no recent activity purchasing the topical analgesic products its name indicates. Business development professionals should verify the correct UNSPSC codes for menthol/petrolatum/pramoxine products before pursuing opportunities tagged to this code.